Christin Melton, ELS

A recent study has shown that extracting cell-free DNA from urine is a highly effective technique for analyzing the genetic profile of urothelial bladder cancers.

Researchers are now searching for chemical or genetic biomarkers that could be used to identify lung cancer patients more likely to develop brain metastases.

Findings from a recent study suggest that women whose breast cancers have a higher proportion of blood vessels may benefit more from neoadjuvant treatment with bevacizumab than women whose tumors have a lower density of blood vessels.

What if the answer to earlier tumor detection is right in front of our faces—or, more accurately, right in front of our dog’s faces?

Representatives Diana DeGette (D, Colorado) and Fred Upton (R, Michigan) recently released a "discussion draft" of the 21st Century Cures Act.

During the past year, many corporations, academic institutions, and government health organizations announced new funding or collaborative efforts totaling billions of dollars to identify genetic targets for novel cancer therapies.